facial laxity
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with facial relaxation, with FLR facial relaxation score ranging from 3 to 8, regardless of gender; aged 30 to 55 years old (including 30 and 55 years old); no other facial treatments received within the past year; after being fully informed of the treatment plan and risks, the patient or guardian voluntarily signs the informed consent form, willing to undergo a self-controlled trial, and cooperate with the follow-up.
Exclusion criteria
Exclusion criteria: Pregnant women or women with fertility plans; allergy to ultrasound coupling agent or topical anesthetics; patients with facial wounds or epidermal ulceration; patients with other skin diseases on the face, such as acne, seborrheic dermatitis, eczema, psoriasis, etc.; patients with severe organic diseases or mental illnesses; patients participating in other clinical trials; patients who have received phototherapy, injection, surgery, or other treatments in the treatment area within the past year; patients undergoing estrogen replacement therapy during menopause; other patients who the researcher believes are not suitable for participation in the trial (such as skin immune diseases, distrust of researchers, etc.).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| FLR Facial Laxity; | — |
Secondary
| Measure | Time frame |
|---|---|
| Global Aesthetic Improvement Score, GAIS;The Fitzpatrick Wrinkle Classification System,FWCS; | — |
Countries
China
Contacts
Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine